Strategic Partnership Eurofins Genomics Americas is actively expanding through collaborations, such as the Jun 2, 2026 Adlin Science partnership, presenting a sales opportunity to offer joint research services, data collaboration, and integrated genomics solutions to shared clients.

Competition Awareness Competitors like Twist Bioscience are identified as peers in DNA synthesis, alongside IDT and GenScript, signaling a market with high activity. This creates a potential sales angle to emphasize Eurofins Genomics’ unique speed, quality, and integrated Eurofins testing ecosystem.

Genomics Services Expansion Recent service launches such as IVT mRNA Synthesis, Express Oxford Nanopore Sequencing with same-day results, and AgriGenomics capabilities indicate ongoing product diversification. A sales opportunity exists to cross-sell these high-demand capabilities to existing biotech and pharma customers seeking end-to-end solutions.

Enterprise Reach As part of Eurofins Scientific with a global footprint of 14,000 staff across 180 laboratories in 35 countries, there is a strong value proposition for customers needing scalable, compliant, and globally available genomics and testing services.

Evidence of Value With a focus on fast turnaround times for DNA synthesis, sequencing, and plasmid-level analyses, potential clients in research, clinical, and environmental spaces can be targeted for bundled offerings that reduce project timelines and improve data quality, supported by Eurofins’ extensive lab network.